Incident Vertebral Fracture Risk in Former, Current Smokers With or Without COPD
Bone attenuation was found to be an independent determinant for vertebral fractures in former smokers with and without chronic obstructive pulmonary disease.
ASBMR 2018
Bone Mineral Density Improved With Intravenous Ibandronate in Osteoporosis
Investigators assessed the effectiveness of intravenous ibandronate on bone mineral density in patients with osteoporosis who did not respond to oral bisphosphonates.
Glucocorticoids Linked to Significant Bone Deficit in Pediatric Crohn Disease
Glucocorticoid therapy was linked to significant bone deficits across multiple axial sites, regardless of disease activity.
MicroRNAs Linked to Increased Cortical Bone Porosity in Postmenopausal Women With History of Fracture
Findings suggest potential pathomechanistic links between miRNAs and cortical porosity. .
Bone Mineral Density Changes After Anastrozole in Postmenopausal Women
In postmenopausal women who were randomly assigned anastrozole, bone mineral density showed significant improvement at the lumbar spine.
Effects of Vitamin D3 Treatment on Bone Strength in Postmenopausal Women
Investigators sought to determine the effects of vitamin D3 supplementation in postmenopausal women with low serum 25(OH)D and high parathyroid hormone levels.
Early Life Exposures Affect Bone Density in Young Adulthood
Early life exposures, such as maternal smoking and breastfeeding, may have effects on bone mineral density in young adulthood.
Drug Holidays May Reduce Risk for Atypical Femur Fracture
Bisphosphonate holidays of 3 to 5 years have been recommended as a means of achieving the antifracture benefit of the medication.
Want to read more?
Please login or register first to view this content.